STEPHEN DAVIS Insider Trading $NRGN NEUROGEN CORP
Get free email notifications about insider trading for STEPHEN DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN DAVIS. STEPHEN DAVIS is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Exec. VP, Chief Oper. Officer in NEUROGEN CORP ($NRGN) and President in NEUROGEN CORP ($NRGN) and President, CEO in NEUROGEN CORP ($NRGN) and Sr VP, Chief Business Officer in NEUROGEN CORP ($NRGN) and Sr VP, Chief Operating Officer in NEUROGEN CORP ($NRGN) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and INTERIM CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and PRESIDENT AND CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
STEPHEN DAVIS in NEUROGEN CORP
Trading Symbol: NRGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: President, CEO, President, Exec. VP, Chief Oper. Officer, Sr VP, Chief Operating Officer, Sr VP, Chief Business Officer
Holdings: 5,979 shares
Latest Transaction: Jul 29 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN DAVIS in NEUROGEN CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, BLCM, HRTX, NRGN, GEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2008 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | President, CEO | Option Exercise | A | 1.20 | 224,000 | 268,800 | 224,000 | |
Apr 28 2008 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Exec. VP, Chief Ope ... | Option Exercise | A | 1.20 | 476,000 | 571,200 | 476,000 | |
Dec 21 2007 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | President | Option Exercise | A | 3.56 | 26,250 | 93,450 | 26,250 | |
Jan 19 2007 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Exec. VP, Chief Ope ... | Option Exercise | A | 6.20 | 120,000 | 744,000 | 120,000 | |
Dec 19 2006 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Exec. VP, Chief Ope ... | Option Exercise | A | 5.78 | 36,400 | 210,392 | 36,400 | |
Dec 20 2005 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Operat ... | Option Exercise | A | 7.88 | 27,720 | 218,434 | 27,720 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | M | 3.87 | 12 | 46 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | M | 3.87 | 17,488 | 67,679 | 0 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Option Exercise | A | 9.05 | 100,000 | 905,000 | 100,000 | |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Grant | A | 9.15 | 487 | 4,456 | 5,979 | 5.5 K to 6 K (+8.87 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Sell | S | 9.55 | 12 | 115 | 50,750 | 50.8 K to 50.8 K (-0.02 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Buy | M | 3.87 | 12 | 46 | 0 | -12 to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Sell | S | 9.00 | 17,488 | 157,392 | 0 | 17.5 K to 0 (-100.00 %) |
Dec 23 2004 | NRGN | NEUROGEN CORP | DAVIS STEPHEN | Sr VP, Chief Busine ... | Buy | M | 3.87 | 17,488 | 67,679 | 0 | -17,488 to 0 (-100.00 %) |
Page: 1